GCG and type 2 diabetes mellitus: In advanced T2D patients, defective beta-cell function leads to a lack of paracrine regulatory factors that normally modulate glucagon release (i.e., insulin) and the resulting glucagon hypersecretion worsens the elevation of liver glucose output associated with the lost inhibitory effect of insulin, even in the fed state.